Supply Chain

Business & Regulation Standards & Regulation

07/12/2022 | Shabbir Imber Safdar | 8 min read

The US drug supply chain is not immune to counterfeits – but there’s a law for that. Here’s how it has been used so far.

Business & Regulation COVID-19

06/08/2022 | Sponsored by Dätwyler

The world wasn’t ready for COVID-19. But if we learn the right lessons, next time next time we’ll do better.

Manufacture Bioprocessing - Upstream & Downstream

05/24/2022 | Michelle Ferreri | 6 min read

COVID-19 has taught us that unexpected events can cause significant supply chain disruption, so pharma must be prepared.

Manufacture Bioprocessing - Upstream & Downstream

04/28/2022 | Sponsored by Cytiva

Cytiva is transforming in the wake of COVID-19 – but what lessons can the wider biopharma industry take forward?

Business & Regulation Supply Chain

04/19/2022 | Sponsored by Thermo Fisher Scientific

The COVID-19 pandemic exposed weaknesses in pharma supply chains. It’s time to address these.

Manufacture Vaccines

04/08/2022 | Serena Fries Smith

Driven by the success of COVID-19 vaccines, mRNA products are expanding drug developers’ pipelines.

Manufacture Supply Chain

04/07/2022 | Maryam Mahdi

Overcoming supply chain woes will require digital intervention.

Business & Regulation Supply Chain

04/04/2022 | Joy Aho

What are the key decisions that need to be made for cell therapy supply chains?

Discovery & Development Business Practice

03/07/2022 | Angus Stewart

The Russian invasion of Ukraine will disrupt and displace a great deal of work in drug discovery. Here’s why.

Manufacture Advanced Medicine

02/17/2022 | Sponsored by MilliporeSigma

How SaudiVax is partnering to help patients in the Middle East and Africa to access advanced medicine.